Introduction
You face a constant formulation challenge when you design stable, effective, and manufacturable dosage forms that rely on non-active ingredients. Raymond C. Rowe and contributors to the Handbook of Pharmaceutical Excipients resolve this problem by establishing that excipients are active functional components rather than inert fillers. You learn that excipients directly govern drug bioavailability, release kinetics, and physical stability through strictly defined physicochemical properties.
The book organizes these insights into detailed monographs and comparative data sets for hundreds of substances. You navigate standardized sections covering physical properties, safety profiles, regulatory status, and functional uses. The handbook answers critical questions to guide your selection process:
- How do specific polymers control drug release rates?
- What mechanisms prevent component interactions in complex formulations?
- Which regulatory standards apply to novel functional excipients?
1. Excipient Definitions and Monograph Architecture
Pharmaceutical excipients are no longer considered merely inert or inactive ingredients. Their properties directly govern the bioavailability, stability, and manufacturability of the final dosage form.
Excipients are active participants in drug delivery rather than inert fillers, structured through 22 standardized monograph sections.
You require detailed knowledge of physical and chemical properties, safety, handling, and regulatory status. Modern drug delivery innovations have introduced novel coprocessed excipient mixtures and physical forms. These developments change how you select materials for complex formulations.
Functional Roles and Innovations
Every substance interacts with pharmaceutically active compounds in specific ways. You must evaluate how these materials perform under stress during manufacturing.
Innovations alter traditional formulation strategies through new material combinations. You encounter these specialized components in advanced delivery systems.
Monograph Structure
Every monograph in the handbook is systematically divided into 22 standardized sections to ensure formulators can easily locate physical properties, safety data, and regulatory information.
These sections cover specific data points for each substance:
- nonproprietary names;
- structural formulas;
- functional categories;
- applications;
- stability and incompatibilities;
- safety profiles;
- pharmacopeial specifications.
2. Binders Disintegrants and Controlled Release Agents
Polymers and hydrocolloids control drug release kinetics and tablet integrity through swelling, gelling, and compaction.
You can select microcrystalline cellulose as a direct-compression tablet binder and diluent. It features a purified and partially depolymerized alpha-cellulose structure manufactured through controlled hydrolysis with dilute mineral acid. Different commercial grades vary in particle size, moisture content, and density.
- Larger particle sizes improve powder flowability for direct compression.
- Low-moisture grades suit moisture-sensitive active ingredients.
- Concentrations range from 20% to 90% for use as a binder or diluent.
- Mean particle sizes span from 20 um to 200 um with true density between 1.512 g/cm3 and 1.668 g/cm3.
Silicified microcrystalline cellulose is an intimate physical mixture of microcrystalline cellulose and colloidal silicon dioxide designed to improve compaction performance. It contains 2% w/w colloidal silicon dioxide bound to the surface and inside particles through co-drying without chemical reaction. You gain greater tensile strength and require lower compression pressures than regular grades.
Cellulose Derivatives and Polymers
Hypromellose grades are identified by a four-digit suffix indicating approximate percentage content of methoxy and hydroxypropoxy groups. The first two digits represent methoxy content percentage, and the second two digits represent hydroxypropoxy percentage. You utilize these polymers as tablet binders, film-coating agents, and extended-release matrices with molecular weights reaching up to 1,500,000.
- Use 2% to 5% w/w for binder applications.
- Use 10% to 80% w/w for matrix release retardation.
Hydroxypropyl cellulose functions as an extended-release matrix former and binder in oral solid dosage forms. Concentrations of 15% to 35% w/w produce extended drug release, whereas 2% to 6% w/w acts as a tablet binder. You find commercial materials spanning molecular weights from 50,000 to 1,250,000.
Investigators studied the sustained release of sulfamethizole from agar beads and the preparation of agar spherules of felodipine. Agar is a dried hydrophilic colloidal polysaccharide extracted from red algae. It acts as a sustained-release agent in gels, beads, microspheres, and tablets following Higuchi kinetics.
Aliphatic polyesters provide biocompatible and biodegradable polymeric matrices for long-acting implantable and injectable drug delivery systems. Polymers such as PLA and PLGA undergo hydrolytic degradation in aqueous environments through the cleavage of ester linkages. They break down into nontoxic hydroxycarboxylic acids with molecular weights typically ranging from 2,000 to over 100,000 Da.
- Package polymers under high-purity dry nitrogen and store in airtight containers refrigerated below 0 degrees Celsius.
- Allow polymers to reach room temperature in a dry environment before opening.
- Re-purge the package with high-purity dry nitrogen prior to resealing after opening.
Natural Gums and Hydrocolloids
Alginic acid acts as a release-modifying, binding, and thickening agent that forms viscous solutions or gels. It is a linear glycuronan polymer extracted from brown seaweed with a molecular weight range of 20,000 to 240,000 and a true density of 1.601 g/cm3. The addition of calcium salts causes crosslinking to create floating gel beads.
- Pour the alginic acid slowly and steadily into vigorously stirred water.
- Stir dispersions for approximately 30 minutes.
- Premix the alginic acid with another powder such as sugar, or a water-miscible liquid such as ethanol (95%) or glycerin, to aid dispersion.
Croscarmellose sodium is a crosslinked polymer of carboxymethylcellulose sodium functioning as a superdisintegrant. It rapidly swells to 4 to 8 times its original volume on contact with water through wicking and swelling mechanisms without forming a gel. You typically apply a concentration of 2% w/w in direct compression.
Crospovidone is a water-insoluble synthetic crosslinked homopolymer of N-vinyl-2-pyrrolidinone used as a fast tablet disintegrant and solubility enhancer. It exhibits high capillary activity and hydration capacity with a 60% maximum moisture sorption. You use concentrations between 2% and 5% in tablets.
Sodium starch glycolate operates as a premier superdisintegrant for tablets and capsules through rapid water uptake and massive volumetric swelling. It is typically used in concentrations between 2% and 8% with an optimum near 4%, and it can swell up to 300 times its volume in water.
3. Solvents Preservatives and Antimicrobial Agents
Liquid vehicles and antimicrobial preservatives maintain microbiological safety and solubility across distinct pH ranges.
Solvents and Cosolvents
Ethanol functions widely as a solvent, disinfectant, antimicrobial preservative, and transdermal penetration enhancer. Aqueous ethanol solutions are bactericidal between 60% and 95% v/v, with 70% v/v generally considered optimal. Its antimicrobial activity is enhanced by edetate salts and inactivated by nonionic surfactants. In transdermal delivery, it acts as a penetration enhancer or co-surfactant. You encounter alcohol with a boiling point of 78.15 degrees Celsius and a flash point in a closed cup of 14 degrees Celsius. The estimated lethal human blood-alcohol concentration ranges from 400 to 500 mg/100 mL.
Isopropyl alcohol serves primarily as a topical solvent and disinfectant, but carries significant toxicity and flammability risks that restrict it from oral and parenteral use. It is bactericidal and acts as a more effective preservative than 95 percent ethanol at concentrations above 70 percent volume-by-volume. Due to its toxicity, unpleasant taste, and degreasing properties, you restrict it to topical applications and film-coating or granulation where it is subsequently removed by evaporation. You apply a 70 percent volume-by-volume aqueous solution as a topical disinfectant, respecting the 400 ppm OSHA 8-hour time-weighted average workplace exposure limit and the 5.05 g/kg rat oral LD50.
Propylene glycol serves as a versatile solvent, extractant, and preservative in parenteral and nonparenteral pharmaceutical formulations. It is a better general solvent than glycerin, dissolving corticosteroids, phenols, sulfa drugs, barbiturates, vitamins, most alkaloids, and many local anesthetics. It is extensively metabolized in the liver to lactic and pyruvic acids. A 2.0% v/v aqueous solution of propylene glycol is iso-osmotic with serum. The WHO set an acceptable daily intake of propylene glycol at up to 25 mg/kg body-weight.
Preservatives and Antiseptics
Benzalkonium chloride is a quaternary ammonium compound widely used as an antimicrobial preservative in ophthalmic, nasal, and otic preparations. It is active against a wide range of bacteria, yeasts, and fungi, but its efficacy is enhanced against certain resistant strains when combined with disodium edetate. You use a typical concentration between 0.01 and 0.02% w/v as a preservative in ophthalmic preparations, noting an estimated fatal oral dose in humans of 1 to 3 g.
Benzyl alcohol acts as a bacteriostatic preservative and local anesthetic in pharmaceutical formulations, though it poses severe toxicity risks in neonates. While commonly utilized in various topical and parenteral solutions, its use in newborn infants has been linked to a fatal toxic syndrome involving metabolic acidosis and respiratory depression known as gasping syndrome. You apply a typical concentration of 1% v/v as an antimicrobial preservative, respecting the 5 mg/kg body-weight daily estimated acceptable daily intake set by WHO.
Methylparaben is widely used as an antimicrobial preservative in pharmaceuticals and cosmetics, showing greater efficacy against yeasts and molds than bacteria. Antimicrobial activity increases with longer alkyl chain length but decreases aqueous solubility. Its efficacy diminishes at higher pH due to phenolate anion formation, and it is most active between pH 4 and 8. Surfactants like polysorbate 80 can reduce its activity via micellization, which can be counteracted by propylene glycol. You use 0.18% methylparaben together with 0.02% propylparaben for parenteral preservation within a pH range of 4 to 8.
4. Lubricants Glidants and Compression Aids
Lubricants and glidants prevent equipment adhesion and ensure powder flow, but require strict control over mixing time and hydrophobicity.
Metallic Stearates and Flow Aids
Magnesium stearate is widely used as a tablet and capsule lubricant, but excessive blending time and concentration can retard dissolution due to its hydrophobicity. Employed at concentrations between 0.25% and 5.0% w/w, magnesium stearate coats powder blends. Long mixing times and high shear can form hydrophobic powder beds that prevent capsule disintegration and decrease tablet crushing strength.
Samyn and Jung investigated in vitro drug release from capsule formulations containing lubricants affected by shear mixing.
Magnesium stearate has a molecular weight of 591.24. Its assay limits for magnesium content on a dried basis are 4.0-5.0%. Sodium stearyl fumarate functions as an effective tablet and capsule lubricant that is less hydrophobic than traditional stearates. Applied at concentrations between 0.5% and 2.0% w/w, it provides a viable alternative when magnesium stearate causes chemical incompatibilities or overly retards tablet dissolution, showing good stability profile over prolonged storage. It has a molecular weight of 390.5 and a melting point range of 224-245°C with decomposition.
Talc functions primarily as a glidant, anticaking agent, and tablet lubricant, and acts as a dissolution retardant in controlled-release solid dosage forms. Because it is a natural hydrous magnesium silicate, sourced grades must be thoroughly screened and certified free of asbestos to eliminate severe carcinogenic and granulomatous risks. You must respect the 1 mg/m3 long-term workplace exposure limit for respirable talc dust in the UK. You can sterilize talc using a protocol of 160 degrees Celsius for at least 1 hour.
Colloidal silicon dioxide is a fumed silica whose submicroscopic particle size and large specific surface area provide excellent glidant properties to improve dry powder flow. It acts as a thixotropic thickening and suspending agent in gels and semisolids. Its viscosity-increasing ability is lost at a pH greater than 10.7 due to dissolution into silicates. Commercial grades have a 15 nm primary particle size and a specific surface area of 100-400 m2/g depending on the grade.
Direct Compression Diluents
Anhydrous lactose is well-suited for moisture-sensitive active ingredients in direct compression tableting due to its very low water content. It typically consists of a mixture of anhydrous beta-lactose and anhydrous alpha-lactose. Commercial anhydrous lactose has a typical composition of 70 to 80 percent anhydrous beta-lactose and 20 to 30 percent anhydrous alpha-lactose. Its maximum water content specification is 1.0 percent, and its typical melting point is 232.0 degrees Celsius. As a reducing sugar, it can undergo Maillard reactions with primary and secondary amines under high humidity and elevated temperatures, leading to drug degradation and discoloration. Trade names include SuperTab 21AN, SuperTab 22AN, and Lactopress Anhydrous.
Lactose monohydrate is a widely used tablet filler and binder, though its clinical use must account for patient lactose intolerance driven by lactase deficiency. Unabsorbed lactose reaching the colon undergoes bacterial fermentation that produces gas and osmotic effects leading to gastrointestinal discomfort. However, most individuals can ingest moderate amounts typical of solid dosage forms without adverse effects. Trade names include Pharmatose, GranuLac, and Tablettose.
In a clinical study, eight out of 13 individuals developed diarrhea after the administration of 20 g of lactose, and nine out of 13 after 25 g.
Lactose monohydrate contains 4.5 to 5.5 percent water of crystallization. Most adults can consume 25 g of lactose per day without symptoms. The rat oral LD50 is 10 to 20 g/kg.
Tragacanth gum is a natural dried exudate from Astragalus species used as a suspending and emulsifying agent in pharmaceutical creams, gels, and emulsions. The gum consists of water-insoluble bassorin (60-70%) and water-soluble tragacanthin. It swells rapidly in water to produce viscous colloidal sols. Stock solutions are vulnerable to enterobacterial contamination and require antimicrobial preservatives like benzoic acid or parabens. Low-quality tragacanth gum is collected naturally from air-dried exudate, whereas higher grades are obtained by making incisions in the trunk and branches held open with wooden pegs. Aqueous dispersions at 1% w/v at 20 °C have a typical viscosity range of 100-4000 mPa s, and the approximate molecular weight is 840,000.
You must follow these preparation steps when compounding with tragacanth:
- prewet powdered tragacanth with a small quantity of a wetting agent such as ethanol (95%), glycerin, or propylene glycol before adding water;
- agitate aqueous dispersions vigorously with a high-speed mixer to prevent lumping;
- mix other powders, such as sucrose, together in the dry state before incorporating into a tragacanth formulation.
5. Coating Polymers and Specialized Delivery Systems
Enteric polymers and lipid carriers direct site-specific release in the gastrointestinal tract and protect sensitive active compounds.
Enteric and Film Coatings
Cellulose acetate phthalate resists strong gastric fluids while dissolving in mildly acidic or neutral intestinal environments. It contains 21.5-26.0% acetyl groups and 30.0-36.0% phthalyl groups with a melting point of 192°C. A 15% w/w solution in acetone exhibits a dynamic viscosity of 50-90 mPa s. You must dissolve cellulose acetate phthalate in the solvent with the greater dissolving power when using mixed solvents. Always add the polymer powder into the solvent and never reverse the order.
Hypromellose acetate succinate acts as an enteric coating agent and solubility-enhancing agent via solid dispersions. Shin-Etsu Chemical supplies grades like Aqoat AS-LF, AS-MF, and AS-HF. These products have molecular weights ranging from 55000 to 93000 Da and a glass transition temperature of 113 degrees Celsius.
Ethylcellulose is a water-insoluble cellulose ether used as a hydrophobic coating agent. You can apply it in concentrations of 1.0-3.0% for standard tablet coating, 3.0-20.0% for sustained-release tablet coating, or 10.0-20.0% for microencapsulation. The glass transition temperature spans from 129 to 1338C.
Polymethacrylates provide synthetic cationic and anionic polymers for pH-dependent enteric coatings. Eudragit L 30 D-55 is applied as an aqueous enteric coating film former that resists gastric juice but dissolves rapidly above pH 5.5 in the small intestine. Aqueous dispersions typically contain 30% polymer dry weight. The UK long-term workplace exposure limit for methyl methacrylate is 208 mg/m3 or 50 ppm, and ammonio methacrylate copolymers have a mean relative molecular mass of 150 000.
Lipid Carriers and Adjuvants
Glyceryl behenate functions as a tablet lubricant and forms lipophilic matrices for sustained-release formulations. Compritol 888 ATO is a commercially prepared glyceryl behenate raw material of vegetable origin atomized by spray-cooling. It requires a 1-monoglyceride content between 12.0% and 18.0% as specified by the USP, melts between 65 and 77°C, and serves in concentrations of 1.0-3.0% as a tablet and capsule lubricant.
Hard fat suppository bases consist of semisynthetic triglyceride mixtures. PhEur hard fat bases feature melting ranges from 30 to 45 degrees Celsius and a density range of 0.950 to 0.980 g/cm3 at 20 degrees Celsius.
You must follow these preparation practices when using hard fat suppository bases:
- condition bases to a stable crystalline form prior to melting point determinations;
- select bases with low hydroxyl values to minimize chemical reactivity;
- employ tempering techniques by precrystallizing the base to prevent surface blooming during molding.
Aluminum hydroxide and aluminum phosphate hydrogels serve as vaccine adjuvants that stimulate Th2 immune responses. Alhydrogel forms primary particles with a specific surface area of 500 m2/g. The FDA sets a maximum aluminum limit of 0.85 mg per dose for human vaccines, whereas the WHO sets this limit at 1.25 mg. You must store these adjuvants between 4 and 30 degrees Celsius and must never freeze them because freezing irreversibly damages their hydrated colloidal structure.
10 Key Ideas
- Pharmaceutical excipients function as active participants in drug delivery rather than inert fillers, structured through 22 standardized monograph sections.
- Polymers and hydrocolloids control drug release kinetics and tablet integrity through swelling, gelling, and compaction.
- Liquid vehicles and antimicrobial preservatives maintain microbiological safety and solubility across distinct pH ranges.
- Lubricants and glidants prevent equipment adhesion and ensure powder flow, but require strict control over mixing time and hydrophobicity.
- Enteric polymers and lipid carriers direct site-specific release in the gastrointestinal tract and protect sensitive active compounds.
- Microcrystalline cellulose serves as a direct-compression tablet binder and diluent with varying particle sizes and moisture contents.
- Croscarmellose sodium, crospovidone, and sodium starch glycolate operate as superdisintegrants that rapidly swell on contact with water through wicking and swelling mechanisms.
- Benzalkonium chloride, benzyl alcohol, and methylparaben provide antimicrobial preservation, though certain agents pose specific toxicity risks such as neonatal gasping syndrome.
- Magnesium stearate acts as a tablet lubricant, but excessive blending time and concentration can retard dissolution due to its hydrophobicity.
- Regulatory safety standards dictate strict limits, including the WHO acceptable daily intake for propylene glycol at up to 25 mg/kg body-weight and the FDA maximum aluminum limit of 0.85 mg per dose for human vaccines.